Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Total Environ ; 512-513: 444-453, 2015 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-25644840

RESUMEN

Incorporation of living organisms, such as photosynthetic organisms, on the structure envelope has become a priority in the area of architecture and construction due to aesthetical, economic and ecological advantages. Important research efforts are made to achieve further improvements, such as for the development of cementitious materials with an enhanced bioreceptivity to stimulate biological growth. Previously, the study of the bioreceptivity of cementitious materials has been carried out mainly under laboratory conditions although field-scale experiments may present different results. This work aims at analysing the colonisation of cementitious materials with different levels of bioreceptivity by placing them in three different environmental conditions. Specimens did not present visual colonisation, which indicates that environmental conditions have a greater impact than intrinsic properties of the material at this stage. Therefore, it appears that in addition to an optimized bioreceptivity of the concrete (i.e., composition, porosity and roughness), extra measures are indispensable for a rapid development of biological growth on concrete surfaces. An analysis of the colonisation in terms of genus and quantity of the most representative microorganisms found on the specimens for each location was carried out and related to weather conditions, such as monthly average temperature and total precipitation, and air quality in terms of NOx, SO2, CO and O3. OPC-based specimens presented a higher colonisation regarding both biodiversity and quantity. However, results obtained in a previous experimental programme under laboratory conditions suggested a higher suitability of Magnesium Phosphate Cement-based (MPC-based) specimens for algal growth. Consequently, carefully considering the environment and the relationships between the different organisms present in an environment is vital for successfully using a cementitious material as a substrate for biological growth.


Asunto(s)
Materiales de Construcción , Ambiente , Microbiología Ambiental , Porosidad
2.
Br J Nutr ; 107(12): 1739-46, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22017795

RESUMEN

D-Fagomine is an iminosugar originally isolated from seeds of buckwheat (Fagopyrum sculentum Moench), present in the human diet and now available as a pure crystalline product. We tested D-fagomine for activities connected to a reduction in the risk of developing insulin resistance, becoming overweight and suffering from an excess of potentially pathogenic bacteria. The activities were: intestinal sucrase inhibition in vitro (rat mucosa and everted intestine sleeves), modulation of postprandial blood glucose in rats, bacterial agglutination and bacterial adhesion to pig intestinal mucosa. When ingested together with sucrose or starch, D-fagomine lowered blood glucose in a dose-dependent manner without stimulating insulin secretion. D-Fagomine reduced the area under the curve (0-120 min) by 20 % (P < 0·01) and shifted the time to maximum blood glucose concentration (Tmax) by 15 min at doses of 1-2 mg/kg body weight when administered together with 1 g sucrose/kg body weight. Moreover, D-fagomine (0·14 mm) agglutinated 60 % of Enterobacteriaceae (Escherichia coli, Salmonella enterica serovar Typhimurium) populations (P < 0·01), while it did not show this effect on Bifidobacterium spp. or Lactobacillus spp. At the same concentration, d-fagomine significantly (P < 0·001) inhibited the adhesion of Enterobacteriaceae (95-99 % cells in the supernatant) and promoted the adhesion of Lactobacillus acidophilus (56 % cells in the supernatant) to intestinal mucosa. D-Fagomine did not show any effect on bacterial cell viability. Based on all this evidence, D-fagomine may be used as a dietary ingredient or functional food component to reduce the health risks associated with an excessive intake of fast-digestible carbohydrates, or an excess of potentially pathogenic bacteria.


Asunto(s)
Bacterias/efectos de los fármacos , Adhesión Bacteriana/efectos de los fármacos , Glucemia/metabolismo , Fagopyrum/química , Hipoglucemiantes/farmacología , Iminopiranosas/farmacología , Extractos Vegetales/farmacología , Animales , Área Bajo la Curva , Bacterias/patogenicidad , Supervivencia Celular/efectos de los fármacos , Dieta , Relación Dosis-Respuesta a Droga , Alimentos Funcionales , Insulina/metabolismo , Resistencia a la Insulina , Secreción de Insulina , Mucosa Intestinal/metabolismo , Masculino , Obesidad/prevención & control , Periodo Posprandial , Ratas , Ratas Sprague-Dawley , Semillas , Sacarasa/antagonistas & inhibidores , Sacarosa/farmacología , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...